Skip to main content

Table 3 The oligonucleotides used in this study

From: Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate

Oligonucleotide

Sequence (5′ to 3′)

Positiona

Lanthanide chelate label or quencher molecule

AMACR forward primer

TTGTCAGGTGTTCTCTCAAA

481–500

 

AMACR reverse primer

CTTCCACCATATTTGCATC

637–655

 

AMACR reporter probe

CbTGAATCTCCTGGCTGACTTTGCTGG

535–560

9d-α gal-EuIII

AMACR quencher probe

TCAGCCAGGAGATTCAGc

535–551

Dabcyl

AR forward primer

GCTGAAGGGAAACAGAAGTAC

328–348

 

AR reverse primer

CTCTCCTTCCTCCTGTAGTTTC

480–501

 

AR reporter probe

TbTGTCGTCTTCGGAAATGTTATGAAGCAGG

408–437

9d-α gal-EuIII

AR quencher probe

AACATTTCCGAAGACGACAAc

408–427

Dabcyl

  1. agene bank accession numbers NM_014324 and NM_001011645 were used for AMACR and AR nucleotide sequences, respectively
  2. binternally amino-modified C6-base for labeling with Eu chelate
  3. cquencher molecule